Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current guidelines].

B Lemke1

  • 1Innere Klinik III, Kardiologie und Angiologie, Klinikum Lüdenscheid, Paulmannshöher Str. 14, 58515 Lüdenscheid. bernd.lemke@rub.de

Herzschrittmachertherapie & Elektrophysiologie
|April 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Acute bradycardia].

Herzschrittmachertherapie & Elektrophysiologie·2020
Same author

Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block.

Clinical research in cardiology : official journal of the German Cardiac Society·2018
Same author

To implant or not to implant? : That is the unsolved question concerning heart failure patients with non-LBBB.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Climate change and occupational health: A South African perspective.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2015
Same author

Do induced tachycardias within the scope of electrophysiological studies lead to elevated plasma troponin I levels?

Herzschrittmachertherapie & Elektrophysiologie·2011
Same author

Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication: male gender and AF in primary ICD prophylaxis.

Herzschrittmachertherapie & Elektrophysiologie·2011
Same journal

[Extrasystoles in endurance athletes].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[AI-Assisted ECG diagnostics : Classical test statistics still apply].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Perioperative complications during transvenous pacemaker and defibrillator implantation].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Late complications after atrial fibrillation ablation : Diagnosis and management].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Herzschrittmachertherapie & Elektrophysiologie·2026
See all related articles

Cardiac resynchronisation therapy (CRT) offers significant benefits for severe systolic heart failure patients. Guidelines vary, with American recommendations stronger than German ones, impacting patient eligibility for this advanced heart failure treatment.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Context:

  • Cardiac resynchronisation therapy (CRT) is a rapidly adopted treatment for severe systolic heart failure.
  • Current American guidelines support CRT with high evidence (Level A, Class IIa).
  • German guidelines offer more moderate recommendations, acknowledging unresolved questions.

Purpose:

  • To evaluate the impact of the COMPANION study on CRT adoption and guideline recommendations.
  • To compare American and German guidelines regarding CRT indications and risk stratification.
  • To inform clinical practice and future guideline development for CRT in heart failure.

Summary:

  • The COMPANION study demonstrated significant benefits of CRT in reducing mortality and hospitalisation.

Related Experiment Videos

  • This led to calls for re-evaluating CRT in German cardiac pacing guidelines.
  • German guidelines employ a risk stratification (Class I, IIa, IIb), differing from American guidelines.

    • Impact:

    • CRT is a crucial therapy for selected heart failure patients, improving outcomes.
    • Guideline discrepancies highlight the need for harmonised international recommendations.
    • Risk stratification aids in optimising patient selection for CRT, enhancing treatment efficacy.